For: | Gastaca M, Ruiz P, Bustamante J, Martinez-Indart L, Ventoso A, Fernandez JR, Palomares I, Prieto M, Testillano M, Salvador P, Senosiain M, Suárez MJ, Valdivieso A. Early tacrolimus exposure does not impact long-term outcomes after liver transplantation. World J Hepatol 2021; 13(3): 362-374 [PMID: 33815678 DOI: 10.4254/wjh.v13.i3.362] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i3/362.htm |
Number | Citing Articles |
1 |
Faiza Ahmed, Faiza Zakaria, Godsgift Enebong Nya, Mohamad Mouchli. Sirolimus <i>vs</i> tacrolimus: Which one is the best therapeutic option for patients undergoing liver transplantation for hepatocellular carcinoma?. World Journal of Gastrointestinal Surgery 2022; 14(8): 862-866 doi: 10.4240/wjgs.v14.i8.862
Abstract(236) |
Core Tip(194) |
Full Article(HTML)(754)
|
Full Article (PDF)-1760K(104)
|
Full Article (Word)-109K(66)
|
Peer-Review Report-460K(26)
|
Answering Reviewers-101K(34)
|
Times Cited (0)
|
Total Visits (2383)
|
Open
|
2 |
Alexandre Destere, Aurélie Premaud, Caroline Monchaud, Pierre Marquet, Jean-Baptiste Woillard. Longitudinal Exposure to Tacrolimus and New-Onset Diabetes Mellitus in Renal Transplant Patients. Therapeutic Drug Monitoring 2023; 45(1): 102 doi: 10.1097/FTD.0000000000001035
|